batirtze-areitio Batirtze Areitio Batirtze has over 5 years of experience in the biopharma and biotech industries. She joined ApexOnco in 2025 after working as an analyst at OncologyPipeline. She is a graduate of the University of Navarra, where she earned a degree in biochemistry. After zolbetuximab investors look for a Claudin18.2 encore 26 March 2024 Another false dawn for Nkarta 22 March 2024 NextCure doubles down on Lair 22 March 2024 Again, Keytruda and PARP fail to lynk 21 March 2024 Innate gets a new lacutamab blow 21 March 2024 BioNTech has some cancer convincing to do 20 March 2024 New Breyanzi approval comes at a timely moment for Allogene 18 March 2024 Takeda ploughs a lonely CD38 furrow 14 March 2024 Load More